{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:07:15Z","timestamp":1782202035144,"version":"3.54.5"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Iron deficiency anemia (IDA) is a prevalent hematological complication associated with gastrointestinal (GI) cancers due to an increased loss of iron and decreased iron absorption. The purpose of this systematic review is to evaluate the use of parenteral iron to treat IDA in patients with GI cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Cochrane, EMBASE, CINHAL and Scopus were searched from January 1, 2010 to September 29, 2023 with no language restrictions. We excluded editorials, case reports, abstracts, conference papers, and poster presentations. Studies were included if they discussed IDA, GI neoplasms, use of iron supplementation (with or without erythropoietin-stimulating agents [ESAs]), defined anemia and had an adult patient population. We assessed the efficacy of parenteral iron in comparison to other iron supplementation methods when treating IDA in patients with GI cancer. The Cochrane Risk of Bias Tool 2 (RoB 2) and the Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) assessment tools were used to assess the quality of the included studies. Moreover, the Cochrane Effective Practice and Organization data collection form was used to collect pertinent study information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our search yielded 3,969 studies across all databases. Twenty-one studies were included (6 randomized control trials; 15 non-randomized studies). Of the 15 studies evaluating hemoglobin (Hb) response, seven studies found an increase in Hb levels when patients were treated with IV iron. The 14 studies evaluating red blood cell (RBC) transfusion rates found conflicting differences in RBC transfusion needs when treated with IV iron. Studies analyzing health related outcomes typically found an increase in quality of life and decreased post-operative complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This review demonstrates improved outcomes of IDA in patients with GI cancer treated with IV iron instead of other iron supplementation methods. Timely diagnosis and appropriate IDA management can greatly improve quality of life in this patient population, especially if myelosuppressive chemotherapy is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0302964","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T13:24:55Z","timestamp":1716384295000},"page":"e0302964","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intravenous iron and iron deficiency anemia in patients with gastrointestinal cancer: A systematic review"],"prefix":"10.1371","volume":"19","author":[{"given":"Shankavi","family":"Nandakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alliya Remtulla","family":"Tharani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Pankiw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4818-318X","authenticated-orcid":true,"given":"Christine","family":"Brezden-Masley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"issue":"1","key":"pone.0302964.ref001","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global Burden of 5 Major Types Of Gastrointestinal Cancer","volume":"159","author":"M Arnold","year":"2020","journal-title":"Gastroenterology"},{"issue":"15","key":"pone.0302964.ref002","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","article-title":"The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients","volume":"40","author":"H Ludwig","year":"2004","journal-title":"Eur J Cancer"},{"key":"pone.0302964.ref003","unstructured":"World Health Organization. Iron deficiency anaemia: Assessment, Prevention, and Control; A guide for programme managers. World Health Organization. 2001;132."},{"key":"pone.0302964.ref004","article-title":"NCCN Guidelines Version 2","author":"GM Rodgers","year":"2018","journal-title":"2018 Panel Members Cancer-and Chemotherapy-Induced Anemia"},{"key":"pone.0302964.ref005","first-page":"1954","author":"Oxford University Press","year":"2012","journal-title":"Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of I.V. iron. Vol. 23, Annals of Oncology"},{"issue":"37","key":"pone.0302964.ref006","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.3748\/wjg.15.4638","article-title":"A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases","volume":"15","author":"F Bermejo","year":"2009","journal-title":"World Journal of Gastroenterology: WJG"},{"issue":"1","key":"pone.0302964.ref007","first-page":"19","article-title":"Iron deficiency in gastrointestinal oncology","volume":"28","author":"K Verraes","year":"2015","journal-title":"Annals of Gastroenterology: Quarterly Publication of the Hellenic Society of Gastroenterology"},{"issue":"4","key":"pone.0302964.ref008","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/ph11040094","article-title":"Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy","volume":"11","author":"F Busti","year":"2018","journal-title":"Pharmaceuticals"},{"key":"pone.0302964.ref009","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/PROM.S169653","article-title":"Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron","volume":"9","author":"WE Strauss","year":"2018","journal-title":"Patient Relat Outcome Meas"},{"issue":"1","key":"pone.0302964.ref010","first-page":"1","article-title":"Role of the initial degree of anaemia and treatment model in the prognosis of gastric cancer patients treated by chemotherapy: A retrospective analysis","volume":"20","author":"WH Li","year":"2020","journal-title":"BMC Cancer"},{"key":"pone.0302964.ref011","article-title":"Preoperative Anemia or Low Hemoglobin Predicts Poor Prognosis in Gastric Cancer Patients: A Meta-Analysis","author":"XZ Huang","year":"2019","journal-title":"Dis Markers"},{"key":"pone.0302964.ref012","author":"JJ Caro","year":"2001","journal-title":"Anemia As an Independent Prognostic Factor for Survival in Patients with Cancer A Systematic, Quantitative Review"},{"issue":"7","key":"pone.0302964.ref013","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjmed.2003.12.008","article-title":"Prevalence and outcomes of anemia in cancer: a systematic review of the literature","volume":"116","author":"K Knight","year":"2004","journal-title":"Am J Med"},{"issue":"23","key":"pone.0302964.ref014","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00508-015-0842-3","article-title":"Iron metabolism and iron supplementation in cancer patients","volume":"127","author":"H Ludwig","year":"2015","journal-title":"Wien Klin Wochenschr"},{"issue":"5","key":"pone.0302964.ref015","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/01635581.2019.1658794","article-title":"Iron Deficiency and Anemia in Cancer Patients: The Role of Iron Treatment in Anemic Cancer Patients","volume":"72","author":"B Abiri","year":"2020","journal-title":"Nutr Cancer"},{"issue":"2","key":"pone.0302964.ref016","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00432-011-1072-3","article-title":"Addition of iron to erythropoiesis-stimulating agents in cancer patients: A meta-analysis of randomized trials","volume":"138","author":"F Petrelli","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"pone.0302964.ref017","doi-asserted-by":"crossref","first-page":"iv96","DOI":"10.1093\/annonc\/mdx758","article-title":"Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines","volume":"29","author":"M Aapro","year":"2018","journal-title":"Ann Oncol"},{"issue":"15","key":"pone.0302964.ref018","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1200\/JCO.18.02142","article-title":"Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO\/ASH clinical practice guideline update","volume":"37","author":"J Bohlius","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"pone.0302964.ref019","article-title":"The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents","author":"R Mhaskar","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"pone.0302964.ref020","first-page":"18","volume":"52","author":"A Gafter-Gvili","year":"2012","journal-title":"Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia\u2013systematic review and meta-analysis of randomised controlled trials"},{"key":"pone.0302964.ref021","first-page":"1","article-title":"Cochrane handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2019","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions"},{"key":"pone.0302964.ref022","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"MJ Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"pone.0302964.ref023","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/asheducation-2010.1.338","article-title":"Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety","volume":"2010","author":"M Auerbach","year":"2010","journal-title":"Hematology"},{"key":"pone.0302964.ref024","unstructured":"Covidence. Veritas Health Innovation, Melbourne, Australia. 2020 [cited 2022 May 31]. Covidence \u2010 Better systematic review management. Available from: https:\/\/www.covidence.org\/."},{"key":"pone.0302964.ref025","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","author":"JPT Higgins","year":"2011","journal-title":"BMJ"},{"key":"pone.0302964.ref026","author":"JA Sterne","year":"2021","journal-title":"Vol. version 6., Cochrane Handbook for Systematic Reviews of Interventions"},{"key":"pone.0302964.ref027","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","author":"LA McGuinness","journal-title":"Res Synth Methods"},{"issue":"10","key":"pone.0302964.ref028","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1111\/codi.15789","article-title":"The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer","volume":"23","author":"RD Bojesen","year":"2021","journal-title":"Colorectal Dis"},{"key":"pone.0302964.ref029","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/IJGM.S165947","article-title":"Role of intravenous iron in the treatment of anemia in patients with gastrointestinal tract tumors undergoing chemotherapy: A single-center, observational study","volume":"11","author":"J Lima","year":"2018","journal-title":"Int J Gen Med"},{"issue":"6","key":"pone.0302964.ref030","first-page":"654","article-title":"The effectiveness of intravenous iron for iron deficiency anemia in gastrointestinal cancer patients: a retrospective study","volume":"30","author":"L Verhaeghe","year":"2017","journal-title":"Ann Gastroenterol"},{"issue":"3","key":"pone.0302964.ref031","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/bjs.10328","article-title":"Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer","volume":"104","author":"BD Keeler","year":"2017","journal-title":"British journal of surgery"},{"issue":"6","key":"pone.0302964.ref032","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/anae.14659","article-title":"The impact of pre-operative intravenous iron on quality of life after colorectal cancer surgery: outcomes from the intravenous iron in colorectal cancer-associated anaemia (IVICA) trial","volume":"74","author":"BD Keeler","year":"2019","journal-title":"Anaesthesia"},{"issue":"4","key":"pone.0302964.ref033","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2352-3026(22)00402-1","article-title":"Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial","volume":"10","author":"K Talboom","year":"2023","journal-title":"Lancet Haematol"},{"key":"pone.0302964.ref034","article-title":"Single-dose intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of post-operative anaemia in colorectal cancer patients: a randomised controlled trial","author":"MJ Laso-Morales","year":"2021","journal-title":"Trasfusione del sangue"},{"issue":"7","key":"pone.0302964.ref035","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1080\/01635581.2018.1504090","article-title":"Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma","volume":"70","author":"O Ng","year":"2018","journal-title":"Nutr Cancer"},{"issue":"3","key":"pone.0302964.ref036","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00384-015-2461-x","article-title":"Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia","volume":"31","author":"JL Calleja","year":"2016","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"pone.0302964.ref037","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1245\/s10434-013-3238-5","article-title":"Effect of intravenous iron supplementation for acute postoperative anemia in patients undergoing gastrectomy for gastric carcinoma: A pilot study","volume":"21","author":"O Jeong","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"pone.0302964.ref038","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00384-020-03508-y","article-title":"Use of intravenous iron therapy in colorectal cancer patient with iron deficiency anemia: a propensity-score matched study","volume":"35","author":"PMH Kam","year":"2020","journal-title":"Int J Colorectal Dis"},{"issue":"12","key":"pone.0302964.ref039","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1111\/trf.14278","article-title":"Preoperative management of colorectal cancer\u2013induced iron deficiency anemia in clinical practice: data from a large observational cohort","volume":"57","author":"MJ Laso-Morales","year":"2017","journal-title":"Transfusion (Paris)"},{"issue":"2","key":"pone.0302964.ref040","first-page":"176","article-title":"Efficacy of intravenous iron III sucrose in decreasing the number of transfusions in patients with colorectal carcinoma not demonstrated","volume":"19","author":"JC Titos-Arcos","year":"2012","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"pone.0302964.ref041","article-title":"The effect of intravenous iron therapy on long-term survival in anemic colorectal cancer patients: results from a matched cohort study","volume":"25","author":"M Wilson","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"pone.0302964.ref042","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/trf.14456","article-title":"Short-term effect of preoperative intravenous iron therapy in colorectal cancer patients with anemia: results of a cohort study","volume":"58","author":"MJ Wilson","year":"2018","journal-title":"Transfusion (Paris)"},{"issue":"2","key":"pone.0302964.ref043","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00384-021-04080-9","article-title":"Preoperative intravenous iron treatment reduces postoperative complications and postoperative anemia in preoperatively anemic patients with colon carcinoma","volume":"37","author":"M Kangaspunta","year":"2022","journal-title":"Int J Colorectal Dis"},{"issue":"6","key":"pone.0302964.ref044","article-title":"Perioperative changes in haemoglobin and ferritin concentrations from preoperative intravenous iron isomaltoside for iron deficiency anaemia in patients with colorectal cancer: A pilot randomised controlled trial","volume":"17","author":"PLP Fung","year":"2022","journal-title":"PLoS One"},{"key":"pone.0302964.ref045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.sopen.2023.09.003","article-title":"Preoperative intravenous iron treatment\u2013a cohort study on colorectal cancer recurrence","volume":"16","author":"M Ploug","year":"2023","journal-title":"Surg Open Sci"},{"key":"pone.0302964.ref046","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jss.2022.03.004","article-title":"Preoperative Intravenous Iron Treatment in Colorectal Cancer: Experience From Clinical Practice","volume":"277","author":"M Ploug","year":"2022","journal-title":"Journal of Surgical Research"},{"key":"pone.0302964.ref047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijsu.2016.12.029","article-title":"Correction of iron-deficiency anaemia in colorectal surgery reduces perioperative transfusion rates: A before and after study","volume":"38","author":"EM Quinn","year":"2017","journal-title":"International Journal of Surgery"},{"issue":"4","key":"pone.0302964.ref048","first-page":"338","article-title":"Intravenous iron administration for post-operative anaemia management after colorectal cancer surgery in clinical practice: A single-centre, retrospective study","volume":"16","author":"MJ Laso-Morales","year":"2018","journal-title":"Blood Transfusion"},{"key":"pone.0302964.ref049","author":"JJ Jones","year":"2021","journal-title":"Ferric Carboxymaltose for Anemic Perioperative Populations: A Systematic Literature Review of Randomized Controlled Trials"},{"issue":"6","key":"pone.0302964.ref050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5581\/1516-8484.20110119","article-title":"Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia","volume":"33","author":"RD Can\u00e7ado","year":"2011","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"4","key":"pone.0302964.ref051","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tmrv.2014.05.004","article-title":"The impact of perioperative iron on the use of red blood cell transfusions in gastrointestinal surgery: a systematic review and meta-analysis","volume":"28","author":"J Hallet","year":"2014","journal-title":"Transfus Med Rev"},{"key":"pone.0302964.ref052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9394060","article-title":"Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions","volume":"2018","author":"A Dignass","year":"2018","journal-title":"Int J Chronic Dis"},{"issue":"4","key":"pone.0302964.ref053","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/172460080602100407","article-title":"Serum ferritin in colorectal cancer patients and its prognostic evaluation","volume":"21","author":"M Lorenzi","year":"2006","journal-title":"Int J Biol Markers"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0302964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T13:25:39Z","timestamp":1716384339000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0302964"}},"subtitle":[],"editor":[{"given":"Pavel","family":"Strnad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0302964","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.09.20.23295822","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,22]]}}}